Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Clinical Research
  • Published:

Use of a Schelin Catheter for analgesia during Rezum treatment of the prostate

Prostate Cancer and Prostatic Diseases volume 27, pages 147–149 (2024)Cite this article

Subjects

Abstract

To further enhance the minimal invasiveness of Rezum treatment (RT), we sought to evaluate the advantages and feasibility of transurethral intraprostatic anesthesia (TUIA) via Schelin Catheter™ (SC). We enrolled 20 men with LUTS due to BPH, who underwent RT using TUIA via SC. Prior to the procedure, patients were asked to rate their pain on a numeric rating scale (NRS) numbered 0–10: with 0 being “No pain” and 10 being “Worst pain”. Median NRS score ranged from 0 to 3. No perioperative procedure-related complications were reported.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Technical description.

Similar content being viewed by others

Data availability

The original contributions presented in the study are included in the article. Further inquiries can be directed to the corresponding author.

References

  1. McVary KT, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, et al. Final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2021;206:715–24.

    Article  PubMed  Google Scholar 

  2. Campobasso D, Siena G, Chiodini P, Conti E, Franzoso F, Maruzzi D, et al. Composite urinary and sexual outcomes after Rezum: an analysis of predictive factors from an Italian multi-centric study. Prostate Cancer Prostatic Dis. 2022.

  3. Eredics K, Wehrberger C, Henning A, Sevcenco S, Marszalek M, Rauchenwald M, et al. Rezūm water vapor therapy in multimorbid patients with urinary retention and catheter dependency. Prostate Cancer Prostatic Dis. 2022;25:302–5. https://doi.org/10.1038/s41391-021-00462-w.

    Article  CAS  PubMed  Google Scholar 

  4. McVary KT, Holland B, Beahrs JR. Water vapor thermal therapy to alleviate catheter-dependent urinary retention secondary to benign prostatic hyperplasia. Prostate Cancer Prostatic Dis. 2020;23:303–8. https://doi.org/10.1038/s41391-019-0187-5.

    Article  PubMed  Google Scholar 

  5. Elterman D, Bhojani N, Vannabouathong C, Chughtai B, Zorn KC. Rezūm therapy for ≥80-mL benign prostatic enlargement: a large, multicentre cohort study. BJU Int. 2022;130:522–7.

    Article  CAS  PubMed  Google Scholar 

  6. Siena G, Tellini R, Cindolo L. Can Rezum stand out as the most versatile and better performing minimally invasive treatment for the management of LUTS related to BPH? Minerva Urol Nephrol. 2022;74:499–501.

    Article  PubMed  Google Scholar 

  7. Siena G, Cindolo L, Ferrari G, Maruzzi D, Fasolis G, Condorelli SV, et al. Water vapor therapy (Rezūm) for lower urinary tract symptoms related to benign prostatic hyperplasia: early results from the first Italian multicentric study. World J Urol. 2021;39:3875–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Schelin S. Transurethral resection of the prostate after intraprostatic injections of mepivacain epinephrine: a preliminary communication. Scand J Urol Nephrol. 2009;43:63–7.

    Article  CAS  PubMed  Google Scholar 

  9. Stenmark F, Brudin L, Stranne J, Peeker R. High-energy feedback microwave thermotherapy and intraprostatic injections of mepivacaine and adrenaline: an evaluation of calculated cell kill accuracy and responder rate. Scand J Urol. 2014;48:374–8.

    Article  CAS  PubMed  Google Scholar 

  10. Cindolo L, Ferrari R, Rabito S, Siena G, Spatafora P, Ferrari G. Rezum procedure with Exime® stent: a step forward to micro-invasiveness. Minerva Urol Nephrol. 2021;73:273–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unit of Oncologic Minimally Invasive Urology and Andrology, Careggi University Hospital, Florence, Italy

    Giampaolo Siena

  2. Unit of Urological Robotic Surgery and Renal Transplantation, Careggi University Hospital, Florence, Italy

    Francesco Sessa

  3. Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

    Francesco Sessa

  4. Department of Urology, Villa Stuart Private Hospital, Rome, Italy

    Luca Cindolo

Authors
  1. Giampaolo Siena
    View author publications

    Search author on:PubMed Google Scholar

  2. Francesco Sessa
    View author publications

    Search author on:PubMed Google Scholar

  3. Luca Cindolo
    View author publications

    Search author on:PubMed Google Scholar

Contributions

GS: project development, data collection, drafting of the manuscript. FS: critical revision of the manuscript, data collection. LC: critical revision of the manuscript, data collection.

Corresponding author

Correspondence to Giampaolo Siena.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Siena, G., Sessa, F. & Cindolo, L. Use of a Schelin Catheter for analgesia during Rezum treatment of the prostate. Prostate Cancer Prostatic Dis 27, 147–149 (2024). https://doi.org/10.1038/s41391-023-00644-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41391-023-00644-8

This article is cited by

Search

Advanced search

Quick links